ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296

ClinicalTrials.gov ID: NCT01575561

Public ClinicalTrials.gov record NCT01575561. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 7:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder

Study identification

NCT ID
NCT01575561
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
377 participants

Conditions and interventions

Interventions

  • Lurasidone Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2012
Primary completion
Jun 30, 2015
Completion
Jun 30, 2015
Last update posted
Aug 21, 2016

2012 – 2015

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Harmonex Neuroscience Research Dothan Alabama 36303
Behavioral Research Specialists, LLC Glendale California 91206
AXIS Clinical Trials Los Angeles California 90036
Excell Research, Inc Oceanside California 92056
Stanford University School of Medicine Research Program VA Palo Alto Health Care System Palo Alto California 93404
SF-Care, Inc. San Francisco California 94117
Neuropsychiatric Research Center of Orange County Santa Ana California 92701
Stanford University School of Medicine Stanford California 93405
Florida Clinical Research LLC Bradenton Florida 34201
Clinical Neuroscience Solutions Inc. Jacksonville Florida 32216
Galiz Research Miami Springs Florida 33166
Clinical Neuroscience Solutions Orlando Florida 32806
Atlanta Center for Medical Research Atlanta Georgia 30308
Clinco Terre Haute Indiana 47802
Activ Med Practices & Research Haverhill Massachusetts 08130
Psych Care Consultants Research St Louis Missouri 63128
Finger Lakes Clinical Research Rochester New York 14618
Charak Clincial Research Center Garlield Heights Ohio 44125
Cutting Edge Research Group Oklahoma City Oklahoma 73116
Suburban Research Associates Media Pennsylvania 19063
Lincoln Research Lincoln Rhode Island 02865
Carolina Clinical Trials Charleston South Carolina 29407
Clinical Neuroscience Solutions Inc. Memphis Tennessee 38119
Psychoneuroendocrinology Research Group, Dept of Psychiatry, UT Southwestern Medical Center Dallas Texas 75235
R/D Clinical Research, Inc. Lake Jackson Texas 77566

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01575561, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2016 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01575561 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →